openPR Logo
Press release

Lyophilization Equipment and Services Market Set to Surge Significantly by 2020

02-24-2017 02:05 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Lyophilization Equipment and Services Market Set to Surge

Lyophilization process is used by pharmaceutical and biotech manufacturing industries in order to expand the life span and reduce the damage to sensitive products such as enzymes, antibodies, blood plasma, proteins and vaccines. Various technological advancements and increasing risk of contamination of high value pharmaceutical products are few of the factors contributing to the growth of the global lyophilization equipment and services market. It is vital for every pharmaceutical organization to maintain the function and efficacy of the drug molecule and prevent it from damage. Furthermore, growth in the number of commercially available vaccines and injectables for various disease conditions and rising demand of contract manufacturing and outsourcing activities in the biopharmaceutical industry is also expected to accentuate the growth of the global lyophilization equipment and services market in the coming few years.

Obtain the PDF containing Upcoming Market Trends of Lyophilization Equipment and Services at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1502

The global lyophilization equipment and services market is segmented by equipment type into bench-top lyophilizers, tray lyophilizers, rotary lyophilizers and freeze drying microscopes. Tray lyophilizers accounted for the largest share of more than 45% of the overall lyophilization equipment market in 2013. The segment is also expected to maintain its lead during the forecast period through 2014 to 2020. Factors that have contributed towards the large market size of tray lyophilizers are vast usage in large scale production systems and long-term stability of pharmaceutical products. Furthermore, lyophilization services are classified into cycle development, aseptic filling and bulk lyophilization. Among these mentioned products, bulk lyophilization accounted for largest market share in 2013 and is expected to grow at an approximate CAGR of over 6.5%. The major factors responsible for such growth of this segment are cost affordability and large volume drying. Similarly, based on applications, the lyophilization equipment and services market is segmented into pharmaceuticals, biopharmaceuticals, diagnostics and nutraceuticals. The pharmaceuticals segment captured the largest market share in 2013 of the total lyophilization equipment and services market. Lyophilization plays an important role in pharmaceutical manufacturing industry as heat-sensitive products are dried at low temperature without hampering its function and physical structure.

Geographically, Europe constituted the largest market share for the global lyophilization equipment and services market in 2013. Factors that have augmented the growth of the lyophilization market in Europe are development of novel technologies pertaining to lyophilization in order to enhance the product portfolio and increased number of clinical trial activities. In addition, ample presence of skilled workforce is also propelling the growth of global lyophilization equipment and services market in Europe. However, Asia Pacific is predicted to foresee the highest growth rate over the forecast period. The rationale behind such high growth has been attributed to favorable government policies, increased adoption of novel technologies and fast growing consumer market. Moreover, increasing scope of contract manufacturing activities in emerging nations such China, India, Malaysia, Thailand and Vietnam and presence of skilled labor would also boost the growth of the global lyophilization equipment and services market in Asia Pacific in the next few years.

Read the Present Market Status of Lyophilization Equipment and Services at: http://www.transparencymarketresearch.com/lyophilization-equipment-services.html

Currently, the lyophilization equipment and services market is highly fragmented due to the involvement of many established and emerging biopharmaceutical companies. Few of the major players operating in the global lyophilization equipment and services market are Lyophilization Technology, Inc., Baxter BioPharma Solutions, GenScript, Inc., ZIRBUS Technology GmbH, Alliance Healthcare Services, Irvine Pharmaceutical Services, Aseptic Technologies, LSNE Contract Manufacturing, W.L. Gore & Associates, Inc., and Biopharma Technologies Ltd.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lyophilization Equipment and Services Market Set to Surge Significantly by 2020 here

News-ID: 448212 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Lyophilization

Lyophilization Services for Biopharmaceuticals Market - CNS Pharmaceuticals, Jub …
Lyophilization Services for Biopharmaceuticals Market Report 2020-2027 includes a comprehensive analysis of the present Market. The report starts with the basic Lyophilization Services for Biopharmaceuticals industry overview and then goes into each and every detail. Lyophilization Services for Biopharmaceuticals Market Report contains in depth information major manufacturers, opportunities, challenges, and industry trends and their impact on the market forecast. Lyophilization Services for Biopharmaceuticals also provides data about the company and its
Spotlight sessions at the upcoming Lyophilization USA Conference
Lyophilization is one of the most time consuming and expensive unit operations. There are many issues within lyopilization which need addressing, and improved drying technologies are needed for current and future products. Featuring an exceptional line-up of keynote speakers from industry leading organisations, SMi's 4th Lyophilization USA conference arrives at the perfect time to discuss novel techniques and advances; regulatory and freeze-drying challenges; finally, alternatives to conventional methods. Agenda highlights will
Achieving Controlled Nucleation During Aseptic Lyophilization
Controlled nucleation is essential for obtaining high-quality lyophilized products with intra- and inter-batch consistency. Two approaches to achieving controlled nucleation have been investigated recently: creating a pressure differential and using an ice fog to insert seed crystals into the vials within the lyophilization chamber. Morrisa Jones, Senior Scientist, Vaccine Drug Product Development Merck, who is speaking at the SMi’s Groups’ Lyophilization USA Conference she will be comparing and contrasting two
Exclusive insight from experts in the lyophilization industry
SMi Group reports: Leaders in the lyophilization industry to share their expertise and knowledge at SMi’s 4th annual conference - Lyophilization USA, November 15 - 16, New Jersey. Recently, event organisers caught up with some of them to discuss key challenges within the lyophilization field. A brief overview from Q&A sessions with: • Fabrice Schlegel - Senior Engineer at Amgen • Mohamed AbouGhaly - Postdoctoral Researcher at Purdue University • Timothy McCoy, Associate Director, Pharmaceutical Development Biologics
Lyophilization USA Conference – official agenda published
SMi Group reports: exploring the future of lyophilization at the established event this November Building on knowledge and experience of the market, SMi Group is pleased to announce the release of the official agenda for the 4th annual Lyophilization USA Conference, which is due to take place in Iselin, New Jersey on November 15 - 16, 2018. Lyophilization is one of the most time-consuming and expensive operations, and improved drying technologies are
Final Reminder: 1 Week Until SMi’s Lyophilization USA
With the event now just 1 week away, a gentle reminder that there is still time to secure your place at SMi's 3rd annual event, Lyophilization USA, taking place on November 16th and 17th in Iselin, New Jersey. Looking to create a competitive edge, reduce manufacturing costs and shorten cycle time through understanding key parameters in pharmaceutical freeze-drying? Receive guidance on QbD submissions? Gain an overview of the latest innovations